πŸ‡ΊπŸ‡Έ FDA
Patent

US 9969742

Imidazotriazinone compounds

granted A61PA61P25/00

Quick answer

US patent 9969742 (Imidazotriazinone compounds) held by IRONWOOD PHARMACEUTICALS, INC. expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
IRONWOOD PHARMACEUTICALS, INC.
Grant date
Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P25/00